A Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)

Recruiting

Phase 1

MK-4646 with RifabutinA Study of Rifabutin and MK-4646 in Healthy Participants (MK-4646-004)

Sponsor:

Merck Sharp & Dohme LLC

Code:

NCT07199452

Conditions

Healthy

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Accepted

Interventions

MK-4646

Rifabutin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-07. This information was provided to ClinicalTrials.gov by Merck Sharp & Dohme LLC on 2025-11-03.